Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Other Accumulated Expenses (2016 - 2023)

Perspective Therapeutics' Other Accumulated Expenses history spans 13 years, with the latest figure at $480000.0 for Q4 2023.

  • On a quarterly basis, Other Accumulated Expenses fell 15.94% to $480000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $480000.0, a 15.94% decrease, with the full-year FY2023 number at $480000.0, down 15.94% from a year prior.
  • Other Accumulated Expenses hit $480000.0 in Q4 2023 for Perspective Therapeutics, up from $24000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for CATX hit a ceiling of $571000.0 in Q4 2022 and a floor of $15000.0 in Q1 2023.
  • Historically, Other Accumulated Expenses has averaged $127300.0 across 5 years, with a median of $96500.0 in 2020.
  • Biggest five-year swings in Other Accumulated Expenses: surged 454.37% in 2022 and later crashed 84.04% in 2023.
  • Tracing CATX's Other Accumulated Expenses over 5 years: stood at $89000.0 in 2019, then rose by 13.48% to $101000.0 in 2020, then rose by 1.98% to $103000.0 in 2021, then surged by 454.37% to $571000.0 in 2022, then fell by 15.94% to $480000.0 in 2023.
  • Business Quant data shows Other Accumulated Expenses for CATX at $480000.0 in Q4 2023, $24000.0 in Q3 2023, and $20000.0 in Q2 2023.